Related Experiment Videos
Hyaluronan synthase expression in pleural malignant mesotheliomas
Naoki Kanomata1, Tomoyuki Yokose, Tomoyuki Kamijo
1Pathology Division, National Cancer Center Research Institute East, 6-5-1 Kashiwanoha, 277-8577 Kashiwa, Chiba, Japan.
Virchows Archiv : an International Journal of Pathology
|February 26, 2005
Summary
Hyaluronan synthase (HAS) 1 and 2 are highly expressed in malignant mesothelioma tumors. HAS1 may serve as a potential diagnostic marker for this cancer, warranting further investigation.
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Background:
- Hyaluronan (HA) is implicated in tumor progression, growth, and metastasis.
- Three isoforms of hyaluronan synthase (HAS) enzymes, responsible for HA production, have been identified.
Purpose of the Study:
- To investigate the expression patterns of HAS isoforms in pleural malignant mesothelioma.
- To compare HAS expression between mesothelioma and pulmonary adenocarcinoma.
Main Methods:
- Analysis of 10 pleural malignant mesothelioma and 20 pulmonary adenocarcinoma cases.
- Immunohistochemical staining using novel antibodies against HAS1, HAS2, and HAS3.
Main Results:
- Malignant mesothelioma showed extensive expression of HAS1 (90%) and HAS2 (90%).
- Pulmonary adenocarcinoma exhibited high HAS2 expression (80%) but lower HAS1 (25%) and HAS3 (20%) expression.
- HAS1 expression was significantly higher in mesotheliomas compared to pulmonary adenocarcinoma (P=0.0036).
Conclusions:
- HAS1 and HAS2 are significantly expressed in malignant mesothelioma.
- Elevated HAS1 expression in mesothelioma suggests its potential as a diagnostic biomarker.
- Larger studies are needed to confirm HAS1 as a definitive marker for malignant mesothelioma.